Abstract
Background
The impact of various post-procedural complications after transcatheter aortic valve implantation (TAVI) on resource use and their consequences in the German reimbursement system has still not been properly quantified.
Methods
In a retrospective observational study, we use data from the German DRG statistic on patient characteristics and in-hospital outcomes of all isolated TAVI procedures in 2013 (N = 9147). The impact of post-procedural complications on reimbursement, length of stay and mechanical ventilation was analyzed using both unadjusted and risk-adjusted linear and logistic regression analyses.
Results
A total of 235 (2.57%) strokes, 583 (6.37%) bleeding events, 474 (5.18%) cases of acute kidney injury and 1428 (15.61%) pacemaker implantations were documented. The predicted reimbursement of an uncomplicated TAVI procedure was €33,272, and bleeding events were associated with highest additional reimbursement (€12,839, p < 0.001), extra length of stay (14.58 days, p < 0.001), and increased likelihood of mechanical ventilation for more than 48 h (OR 17.91, p < 0.001). A more moderate complication-related impact on resource use and reimbursement was found for acute kidney injury (additional reimbursement: €5963, p < 0.001; extra length of stay: 7.92 days, p < 0.001; ventilation >48 h: OR 6.93, p < 0.001) as well as for stroke (additional reimbursement: €4125, p < 0.001; extra length of stay: 4.68 days, p < 0.001; ventilation >48 h: OR 5.73, p < 0.001). Pacemaker implantations, in contrast, were associated with comparably small increases in reimbursement (€662, p = 0.006) and length of stay (3.54 days, p = 0.006) and no impaired likelihood of mechanical ventilation more than 48 h (OR 1.22, p = 0.156). Interestingly, these complication-related consequences remain mostly unchanged after baseline risk-adjustment.
Conclusions
Post procedural complications such as bleeding events, acute kidney injuries and strokes are associated with increased resource use and substantial amounts of additional reimbursement in Germany, which has important implications for decision making outside of the usual clinical sphere.
Similar content being viewed by others
References
Reinöhl, J., Kaier, K., Reinecke, H., Schmoor, C., Frankenstein, L., Vach, W., Cribier, A., Beyersdorf, F., Bode, C., Zehender, M.: Effect of availability of transcatheter aortic valve replacement on clinical practice. N. Engl. J. Med. 373, 2438–2447 (2015)
Gada, H., Agarwal, S., Marwick, T.H.: Perspective on the cost-effectiveness of transapical aortic valve implantation in high-risk patients: outcomes of a decision-analytic model. Ann. Cardiothorac. Surg. 2012(1), 145–155 (2012)
Orlando, R., Pennant, M., Rooney, S., Khogali, S., Bayliss, S., Hassan, A., Moore, D., Barton, P.: Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation. Health Technol. Assess. 17, (2013)
Reynolds, M.R., Magnuson, E.A., Wang, K., Lei, Y., Vilain, K., Walczak, J., Kodali, S.K., Lasala, J.M., O’Neill, W.W., Davidson, C.J., Smith, C.R., Leon, M.B., Cohen, D.J., PARTNER Investigators: Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation 125, 1102–1109 (2012)
Watt, M., Mealing, S., Eaton, J., Piazza, N., Moat, N., Brasseur, P., Palmer, S., Busca, R., Sculpher, M.: Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart 98, 370–376 (2012)
Neyt, M., Van Brabandt, H., Devriese, S., Van De Sande, S.: A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open 2, e001032–e001032 (2012)
Gutmann, A., Kaier, K., Sorg, S., von zur Mühlen, C., Siepe, M., Moser, M., Geibel, A., Zirlik, A., Ahrens, I., Baumbach, H.: Analysis of the additional costs of clinical complications in patients undergoing transcatheter aortic valve replacement in the German Health Care System. Int. J. Cardiol. 179, 231–237 (2015)
Reinöhl, J., Gutmann, A., Kollum, M., von zur Mühlen, C., Baumbach, H., Avlar, M., Moser, M., Bode, C., Zehender, M.: Transfemoral aortic valve implantation: bleeding events, related costs and outcomes. J. Thromb. Thrombolysis 35, 469–475 (2013)
Sinzobahamvya, N., Kopp, T., Arenz, C., Blaschczok, H.C., Hraska, V., Asfour, B.: Reimbursement by current German Diagnosis-Related Groups system penalises complex congenital heart surgery. Cardiol. Young 24, 344–350 (2014)
Qvick, B., Buehren, V., Woltmann, A.: Ist ein Polytrauma heutzutage noch bezahlbar?: g-DRG-System vs. Tagessätze anhand 1030 polytraumatisierter Patienten. Unfallchirurg 115, 892–896 (2012)
Bauer, M., Ostermann, H.: DRGs in transfusion medicine and hemotherapy in Germany. Transfus. Med. Hemother. 39, 60–66 (2012)
Schreyögg, J., Tiemann, O., Busse, R.: Cost accounting to determine prices: how well do prices reflect costs in the German DRG-system? Health Care Manag. Sci. 9, 269–279 (2006)
Hoehn, T., Drabik, A., Lehmann, C., Christaras, A., Stannigel, H., Mayatepek, E.: Correlation between severity of disease and reimbursement of costs in neonatal and paediatric intensive care patients. Acta Paediatr. 97, 1438–1442 (2008)
Vogl, M.: Assessing DRG cost accounting with respect to resource allocation and tariff calculation: the case of Germany. Health Econ. Rev. 2, 15 (2012)
Malyar, N., Furstenberg, T., Wellmann, J., Meyborg, M., Luders, F., Gebauer, K., Bunzemeier, H., Roeder, N., Reinecke, H.: Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a nationwide population-based analysis. Eur. Heart J. 34, 2706–2714 (2013)
Freisinger, E., Fuerstenberg, T., Malyar, N.M., Wellmann, J., Keil, U., Breithardt, G., Reinecke, H.: German nationwide data on current trends and management of acute myocardial infarction: discrepancies between trials and real-life. Eur. Heart J. 35, 979–988 (2014)
Reinöhl, J., K. Kaier, Reinecke, H., Schmoor, C., Frankenstein, L., Vach, W., Cribier, A., Beyersdorf, F., Bode, C., Zehender, M.: Effect of availability of transcatheter aortic valve replacement on clinical practice: supplementary appendix. N. Engl. J. Med. 373, 2438–2447 (2015)
Roques, F., Michel, P., Goldstone, A.R., Nashef, S.A.M.: The logistic euroscore. Eur. Heart J. 24, 882 (2003)
Heinz, J., Fiori, W., Heusser, P., Ostermann, T.: Cost analysis of integrative inpatient treatment based on DRG data: the example of anthroposophic medicine. Evid. Based Complement. Alternat, Med (2013)
Quentin, W., Geissler, A., Scheller-Kreinsen, D., Busse, R.: DRG-type hospital payment in Germany: the G-DRG system. Euro. Obs. 12, 4–6 (2010)
Braun, J.-P., Bause, H., Bloos, F., Geldner, G., Kastrup, M., Kuhlen, R., Markewitz, A., Martin, J., Mende, H., Quintel, M.: Peer reviewing critical care: a pragmatic approach to quality management. GMS Ger. Med. Sci. 8, (2010)
Cao, C., Liou, K., Pathan, F., Virk, S., McMonnies, R., Wolfenden, H., Indraratna, P.: Transcatheter aortic valve implantation versus surgical aortic valve replacement: meta-analysis of clinical outcomes and cost-effectiveness. Curr. Pharm, Des (2016)
Kappetein, A.P., Head, S.J., Généreux, P., Piazza, N., Van Mieghem, N.M., Blackstone, E.H., Brott, T.G., Cohen, D.J., Cutlip, D.E., van Es, G.-A.: Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J. Am. Coll. Cardiol. 60, 1438–1454 (2012)
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kaier, K., Reinecke, H., Naci, H. et al. The impact of post-procedural complications on reimbursement, length of stay and mechanical ventilation among patients undergoing transcatheter aortic valve implantation in Germany. Eur J Health Econ 19, 223–228 (2018). https://doi.org/10.1007/s10198-017-0877-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10198-017-0877-7
Keywords
- Post-procedural complications
- TAVR
- Transcatheter aortic valve replacement
- Excess costs
- Reimbursement
- Resource use